Of the 46 patients with TSC prescribed an mTOR inhibitor, 16 (21%) were prescribed Everolimus, all but one of these for renal angiomyolipoma, with one patient taking the drug for combined renal and lung disease. This evidence concerns the gene MTOR and lung disorder.